1,3-Benzodioxole-5-carboxylic acid → 1-(1,3-Benzodioxol-5-ylcarbonyl)-1,2,3,6-tetrahydro-pyridine

HRID 1458522ノート

反応式

HRID 1458522 の反応式
[C:1]([C:8]1NC=CN=1)([C:3]1[NH:4][CH:5]=[CH:6]N=1)=O.[C:13](O)(=[O:23])[C:14]1[CH:22]=[CH:21][C:20]2[O:19][CH2:18][O:17][C:16]=2[CH:15]=1.C(Cl)(=O)C1C=CC2OCOC=2C=1.N1CC=CCC1>>[O:19]1[C:20]2[CH:21]=[CH:22][C:14]([C:13]([N:4]3[CH2:5][CH:6]=[CH:8][CH2:1][CH2:3]3)=[O:23])=[CH:15][C:16]=2[O:17][CH2:18]1

参加物

5

反応物 4

HCID 71961,3-Benzodioxole-5-carboxylic acidHCID 127501,2,3,6-TetrahydropyridineHCID 27347491,3-Benzodioxole-5-carbonyl chlorideHCID 5250894Bis-(1H-imidazol-2-YL)-methanone

生成物 1

HCID 117760631-(1,3-Benzodioxol-5-ylcarbonyl)-1,2,3,6-tetrahydro-pyridine

実験手順

The product amide is made by the method employed for the preparation of Invention Compound V, which uses carbonyl diimidazole in order to activate piperonylic acid, or piperonyloyl chloride (available from Aldrich) can be combined with 1,2,3,6-tetrahydropyridine either in a suitable anhydrous solvent or without solvent. In either case, the isolation of product is performed in the same manner as done for Invention Compound V to give Invention Compound III as a white solid. EIMS m/z=231 (parent, 149 (base), and 121. 1H NMR δ 2.21 (br s, 2), 3.4-4.3 (br m, 4), 5.87 (m, 2), 6.00 (s, 2), 6.83 (d, 1, J=7.84 Hz), and 6.92-6.96 (dd and d, 2). 13C NMR δ 101.3 (--OCH2O--) and 169.9 ppm (carbonyl).

出典と根拠

ORDレコード
ord-7831979740fd4f97a9d3508258c224f9
出典データセット
uspto-grants-1998_12
特許番号
US05852008

反応ノート

読み込み中…